APA (7th ed.) Citation

Cheng, Y., Song, Z., Fang, X., & Tang, Z. (2024). Polycomb repressive complex 2 and its core component EZH2: Potential targeted therapeutic strategies for head and neck squamous cell carcinoma. Clinical Epigenetics, 16(1), 1. https://doi.org/10.1186/s13148-024-01666-2

Chicago Style (17th ed.) Citation

Cheng, Yuxi, Zhengzheng Song, Xiaodan Fang, and Zhangui Tang. "Polycomb Repressive Complex 2 and Its Core Component EZH2: Potential Targeted Therapeutic Strategies for Head and Neck Squamous Cell Carcinoma." Clinical Epigenetics 16, no. 1 (2024): 1. https://doi.org/10.1186/s13148-024-01666-2.

MLA (9th ed.) Citation

Cheng, Yuxi, et al. "Polycomb Repressive Complex 2 and Its Core Component EZH2: Potential Targeted Therapeutic Strategies for Head and Neck Squamous Cell Carcinoma." Clinical Epigenetics, vol. 16, no. 1, 2024, p. 1, https://doi.org/10.1186/s13148-024-01666-2.